Medis Consulting conducted a Systematic Literature Review (SLR) to document the evidence base linking hospital design elements on patient outcomes for a large global engineering firm.

Medis Consulting conducted an online survey in the US, Europe, and LATAM to quantify the value of various clinical profiles for an novel therapy in development for an ultra-orphan CNS indication.

A mid-sized pharmaceutical company with a leading second generation antihistamine knew they were not maximizing their Direct to Consumer (DTC) impact in the US.  We repositioned the brand with patients and led to more compelling messages and increased sales.

A manufacturer of primarily generic products had made an advancement in the formulation of a standard hospital antibiotic.  They wanted to bring two novel formulations to market and asked us to provide insights on the likely use and appropriate pricing of each formulation.

A leading pharmaceutical company had a unique challenge.  One of their old respiratory products continued to sell well long after they stopped supporting it.  We helped them understand who was using the product and why, and how they could cost effectively build their revenues further.

A leading pharmaceutical company faced the launch of one or more biosimilars on one of their leading products.  We helped them understand the likely market events and build a strategy to address them.

A large pharmaceutical company was launching a novel compound into an orphan oncology space and wanted to segment payers in order to anticipate the response and ensure the best possible access.

A large pharmaceutical client with a significant respiratory portfolio was interested in better partnering with experts in US health systems.  They ask us to find a representative group of in-house experts and identify opportunities, drivers, and barriers to partnership.

A large pharmaceutical company needed to reorganize their US hospital sales force to better address the changing dynamics of hospital systems.  We gathered insights in three pilot markets to improve their sales approach to better reflect the interests of their organized clients.

A large global pharmaceutical company had a hematology product that had long since been surprised by newer drugs, but still brought in significant revenues.  They asked us to produce a pricing tracker to improve their ability to respond and predict multiple markets and refine their value strategy.